Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Geo Group Inc (The) REIT (GEO) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Geo Group Inc (The) REITTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Geo Group Inc (The) REIT vs Recursion Pharmaceuticals Inc — how do they compare? Geo Group Inc (The) REIT trades at $31.07 (market cap $4.07B), while Recursion Pharmaceuticals Inc trades at $4.41 (market cap $2.14B). The key difference: Geo Group Inc (The) REIT is the larger of the two by market cap, and Geo Group Inc (The) REIT is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Geo Group Inc (The) REIT for 1 Days and Recursion Pharmaceuticals Inc for 23 Days on average.

GEORXRX
Market Cap
$4.07B$2.14B
Volume
3,991,49230,789,535
Sector
IndustrialsHealth
52-Week High
$32.77$6.79
52-Week Low
$13.26$2.84
Typical Hold Time
1 Days23 Days
Enterprise Value
$5.63B$1.66B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Geo Group Inc (The) REIT

No Aura AI signal available yet.

Recursion Pharmaceuticals Inc

RXRX trades at $4.36, up 2.11% today, with technical indicators showing a bullish trend. The company reported Q3 2026 revenue of $54 million but continues to post significant losses with a -961.97% net income margin. Recent strategic partnerships with Tempus and Roche are expanding its AI-driven drug pipeline, though the stock faces high short interest and substantial cash burn from operations.

The outlook remains speculative given persistent losses and high valuation multiples (P/S 37.14), but analyst consensus leans positive with 40% buy ratings. Key risks include execution on drug development timelines and dependence on financing activities to fund operations. Upside potential hinges on successful clinical milestones from its expanding pipeline.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEO

No sentiment data available yet.

RXRX
86% Buy14% Sell
Avg holding period · 23 Days

About Geo Group Inc (The) REIT

The GEO Group provides correctional, detention, and community reentry services. Its operations include secure facilities, electronic monitoring, and support programs for individuals in the criminal-justice system.

Read more on GEO →

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX →